Calyxt, Inc. (NASDAQ:CLXT) had its price target raised by Jefferies Group LLC to $27.00 in a research report sent to investors on Wednesday, The Fly reports. Jefferies Group LLC currently has a buy rating on the stock.

A number of other equities research analysts have also issued reports on the stock. Zacks Investment Research lowered shares of Calyxt from a hold rating to a sell rating in a research note on Monday, October 16th. Wells Fargo & Company upped their target price on shares of Calyxt from $17.00 to $30.00 and gave the company an outperform rating in a research note on Friday, September 29th. Citigroup Inc lowered shares of Calyxt from a buy rating to a neutral rating in a research note on Wednesday, September 27th. Finally, BMO Capital Markets started coverage on shares of Calyxt in a research note on Monday, October 30th. They issued an outperform rating and a $32.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. Calyxt has an average rating of Hold and an average price target of $26.25.

Calyxt (NASDAQ:CLXT) opened at $22.20 on Wednesday.

ILLEGAL ACTIVITY WARNING: “Jefferies Group LLC Raises Calyxt, Inc. (CLXT) Price Target to $27.00” was first reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at https://www.watchlistnews.com/jefferies-group-llc-raises-calyxt-inc-clxt-price-target-to-27-00/1677094.html.

About Calyxt

Calyxt, Inc is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics.

The Fly

Receive News & Ratings for Calyxt Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.